The randomized, double blind study phase III.b of the Comprehensive assessment of the musculoskeletal health in children with cystic fibrosis – on the search for means of improvement

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517886-18-00

Acronym

COAM-CFD-01

Enrollment

Registered

2024-10-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bone density, Cystic fibrosis and problems with bone metabolism, skeletal muscle force

Brief summary

Serum concentrations of 25-OH vitamin D and parathormone at visits V3-V7, Lumbar Spine aBMD at visit V7, Dynamic muscle force and power at visit V7

Interventions

DRUGVigantol 0

DRUG5 mg/ml perorální kapky

DRUGroztok

Eligibility

Sex/Gender

All

Age

0 Years to 17 Years

Design outcomes

Primary

Measure	Time frame
Serum concentrations of 25-OH vitamin D and parathormone at visits V3-V7, Lumbar Spine aBMD at visit V7, Dynamic muscle force and power at visit V7	—

Countries

Czechia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026